SCHEMBL331741

SCHEMBL331741

CNC1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL331622 0.96
Hydrochloric Acid SCHEMBL1775843 0.93
SCHEMBL168531 0.92
Cyanide SCHEMBL28289304 0.90
SCHEMBL1485899 0.89 ALDH1A1 (0.53)
SCHEMBL8918 0.89
Hydrochloric Acid SCHEMBL561323 0.89
SCHEMBL13166298 0.89 ALDH1A1 (0.53)
SCHEMBL1148684 0.89
SCHEMBL3036481 0.89 ALDH1A1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1820 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115109036-B Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-06-11 CN claimed
US-20240150346-A1 CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF INNOVSTONE THERAPEUTICS LIMITED (CN) 2024-05-09 US claimed
CN-115894486-B Hydrogenated pyridoquinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-02-09 CN claimed
EP-4293016-A1 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2023-12-20 EP claimed
CN-113527215-B Quinazoline compound, preparation method and application thereof 北京赛特明强医药科技有限公司 2023-12-05 CN claimed
US-20230257374-A1 NOVEL KRAS G12C PROTEIN INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF INNOVENT BIOLOGICS (SUZHOU) CO., LTD. (CN) 2023-08-17 US claimed
CN-114555586-B KRASG12C protein inhibitor and preparation method and application thereof 信达生物制药(苏州)有限公司 2023-06-23 CN claimed
US-20230131260-A1 SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS SYNGENTA CROP PROTECTION AG (CH) 2023-04-27 US claimed
WO-2023051687-A1 QUINAZOLINE COMPOUND, COMPOSITION, AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2023-04-06 WO claimed
CN-115894383-A Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2023-04-04 CN claimed
US-20060004051-A1 Compounds DODIC NERINA 2006-01-05 US claimed
US-20050234044-A1 Cyclic amine derivatives and methods of use AMGEN INC. 2005-10-20 US claimed
EP-1554275-A2 COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2005-07-20 EP claimed
WO-2005061467-A2 PIPERAZINE DERIVATIVES AS BRADYKININ ANTAGONISTS AMGEN INC. (US) 2005-07-07 WO claimed
US-20050124654-A1 Compounds and methods of use AMGEN INC. 2005-06-09 US claimed
US-20050014749-A1 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects AMGEN INC. 2005-01-20 US claimed
WO-2004092116-A1 BICYCLIC COMPOUNDS HAVING BRADYKININ RECEPTORS AFFINITY AND PHARMACEUTICAL COMPOSITIONS THEREOF AMGEN, INC. (US) 2004-10-28 WO claimed
WO-2004092164-A1 CYCLIC AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATION-RELATED DISORDERS MEDIATED BY BRADYKININ AMGEN, INC. (US) 2004-10-28 WO claimed
WO-2004013134-A2 COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-12 WO claimed
WO-2002081473-A1 SUBSTITUTED AZOLOAZIN(THI)ONES BAYER CROPSCIENCE AG (DE) 2002-10-17 WO claimed